ImmunoMind helps select the best T-cell therapy candidates early by assessing and comparing their designs with single-cell precision. ImmunoMind's Augmented Intelligence platform is based on proprietary single-cell multi-omics technologies to automatically evaluate 14 essential T-cell population characteristics – exhaustion, persistence, immune profile, and more. The platform guides translational and clinical research to improve the probability of success in later drug development stages.
UC Berkeley SkyDeck’20 Alumnus.
UC Berkeley SkyDeck’20 Alumnus.
Location: Australia, New South Wales, Berkeley
Employees: 11-50
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | Berkeley S... | skydeck.be... |
Mentions in press and media 1
| Date | Title | Description |
| 18.08.2020 | Attending a remote startup accelerator is absolutely worth it | SkyDeck Spring 2020 Cohort Contributor UC Berkeley SkyDeck is the startup accelerator of the University of California at Berkeley. We are members of the UC Berkeley SkyDeck startup accelerator spring 2020 cohort — the first to attend remote... |